REFERENCES
- Curry SC, Chang D, Connor D. Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med 1989; 18: 1068–1084, [PUBMED], [INFOTRIEVE]
- Salluzzo RF. Rhabdomyolysis. Emergency Medicine: Concepts and Clinical Practice, AL Rosenet. Mosby, St. Louis, MO 1992
- Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem 2000; 37: 581–587, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Better OS, Stain JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990; 322: 825–827, [PUBMED], [INFOTRIEVE]
- Ayer G, Grandchamp A, Wyler T, Truniger B. Intrarenal hemodynamics in glycerol-induced myohemoglobinuric acute renal failure in the rat. Circ Res 1971; 29: 128–135, [PUBMED], [INFOTRIEVE]
- Hsu CH, Kurtz TW, Waldinger TP. Cardiac output and renal blood flow in glycerol-induced acute renal failure in the rat. Circ Res 1977; 40: 178–182, [PUBMED], [INFOTRIEVE]
- Ruilope LM, Lahera V, Rodicio JL, Romero JC. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens 1994; 12: 625–631, [PUBMED], [INFOTRIEVE]
- Mundel P, Bachmann S, Bader M, et al. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 1992; 42: 1017–1019, [PUBMED], [INFOTRIEVE]
- Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1990; 1: 875–881, [PUBMED], [INFOTRIEVE]
- King AJ, Troy JL, Anderson S, Neuringer JR, Gunning M, Brenner BM. Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J Am Soc Nephrol 1991; 1: 1271–1277, [PUBMED], [INFOTRIEVE]
- Das DK, Sato M, Ray PS, et al. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res 1999; 25: 115–120, [PUBMED], [INFOTRIEVE]
- Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Rad Biol Med 1999; 27: 160–169, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bertelli AA, Giovannini L, Bernini W, et al. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 1996; 22: 61–63, [PUBMED], [INFOTRIEVE]
- Ferrero ME, Bertelli AA, Pellegatta F, Fulgenzi A, Corsi MM, Bertelli A. Phytoalexin resveratrol (3–4′-5-trihydroxystilbene) modulates granulocyte and monocyte endothelial adhesion. Transplant Proc 1998; 30: 4191–4193, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bastianetto S, Zheng WH, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 2000; 131: 711–720, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Giovannini L, Migliori M, Longoni BM, et al. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 2001; 37: 262–270, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 1979; 95: 351–357, [CROSSREF]
- Varley H. The plasma proteins. Practical Clinical Biochemistry, H Varley. CBS, Delhi 1989; 236–238
- Chander V, Singh D, Chopra K. Attenuation of glycerol-induced acute renal failure in rats by trimetazidine and deferoxamine. Pharmacology 2003; 67: 41–48, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jollow DJ, Mitchell LR, Zampaglione N, Gillete JR. Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 1974; 11: 151–156, [PUBMED], [INFOTRIEVE]
- Claiborne A. CRC Handbook of Methods for Oxygen Radical Reaserch, RA Greenwald. CRC Press, Boca Raton, Fla 1985; 283–287
- Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978; 186: 189–195, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bywaters RG, Beall D. Crush injuries with impairment of renal function. Br Med J 1941; 1: 427–432
- Ron D, Taitelman U, Michaelson M, Bar-Joseph G, Bursztein S, Better OS. Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Int Med 1984; 144: 277–280, [CROSSREF]
- Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 1974; 291: 807–811, [PUBMED], [INFOTRIEVE]
- Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314–326, [PUBMED], [INFOTRIEVE]
- Acute Renal Failure, A Dubrow, W Flamenbaum, BM Brenner, JM Lazarus. Churchill Livingstone, New York, NY 1988
- Venkatachalan MA, Rennke HG, Sandstorm DJ. The vascular basis for acute renal failure in the rat. Preglomerular and postglomerular vasoconstriction. Circ Res 1976; 38: 267–269
- Valdivielso JM, Lopez-Novoa JM, Eleno N, Perez Barriocanal F. Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can J Physiol Pharmacol 2000; 78: 476–482, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988; 255: F539–F544, [PUBMED], [INFOTRIEVE]
- Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 1988; 255: F438–F443, [PUBMED], [INFOTRIEVE]
- Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanisms and therapeutic implications. J Clin Invest 1992; 90: 711–716, [PUBMED], [INFOTRIEVE]
- Abull-Ezz SR, Walker PD, Shah SV. Role of glutathione in an animal model of myoglobinuric acute renal failure. Proc Nat Acad Sci USA 1991; 88: 9833–9837
- Nath KA, Balla G, Vercellotti GM, et al. Induction of heme oxygenase is a rapid protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267–270, [PUBMED], [INFOTRIEVE]
- Oken DE, Arce ML, Wilson DR. Glycerol-induced hemoglobinuric acute renal failure in the rat. I. Micropuncture study of the development of oliguria. J Clin Invest 1966; 45: 724–735, [PUBMED], [INFOTRIEVE]
- Constant J. Alcohol, ischemic heart disease, and the French paradox. Clin Cardiol 1997; 20: 420–424, [PUBMED], [INFOTRIEVE]
- Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985; 834: 275–278, [PUBMED], [INFOTRIEVE]
- Ragazzi E, Froldi G, Fassina G. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol Res Comm 1988; 20: 79–82
- Jayatilake GS, Jayasuriya H, Lee ES, et al. Kinase inhibitors from Polygonum cuspidatum. J Nat Prod 1993; 56: 1805–1810, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103–1104, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rotondo S, Rajtar G, Manarini S, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998; 123: 1691–1699, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fremont L. Biological effects of resveratrol. Life Sci 2000; 66: 663–673, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bradamante S, Barenghi L, Piccinini F, et al. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 2003; 465: 115–123, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hung LM, Su MJ, Chen JK. Resveratrol protects myocardial ischemia-reperfusion injury through both no-dependent and no-independent mechanisms. Free Rad Biol Med 2004; 36: 774–781, [PUBMED], [INFOTRIEVE], [CROSSREF]